570 related articles for article (PubMed ID: 21245182)
41. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study.
Suvanto-Luukkonen E; Koivunen R; Sundström H; Bloigu R; Karjalainen E; Häivä-Mällinen L; Tapanainen JS
Menopause; 2005; 12(1):18-26. PubMed ID: 15668596
[TBL] [Abstract][Full Text] [Related]
42. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
Loprinzi CL; Levitt R; Barton D; Sloan JA; Dakhil SR; Nikcevich DA; Bearden JD; Mailliard JA; Tschetter LK; Fitch TR; Kugler JW
J Clin Oncol; 2006 Mar; 24(9):1409-14. PubMed ID: 16505409
[TBL] [Abstract][Full Text] [Related]
43. Quantitative study on the efficacy of acupuncture in the treatment of menopausal hot flashes and its comparison with nonhormonal drugs.
Li T; Zhang Y; Cheng Q; Hou M; Zheng X; Zheng Q; Li L
Menopause; 2021 Mar; 28(5):564-572. PubMed ID: 33739313
[TBL] [Abstract][Full Text] [Related]
44. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
[TBL] [Abstract][Full Text] [Related]
45. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.
Pockaj BA; Gallagher JG; Loprinzi CL; Stella PJ; Barton DL; Sloan JA; Lavasseur BI; Rao RM; Fitch TR; Rowland KM; Novotny PJ; Flynn PJ; Richelson E; Fauq AH
J Clin Oncol; 2006 Jun; 24(18):2836-41. PubMed ID: 16782922
[TBL] [Abstract][Full Text] [Related]
46. Urtica dioica in comparison with placebo and acupuncture: A new possibility for menopausal hot flashes: A randomized clinical trial.
Kargozar R; Salari R; Jarahi L; Yousefi M; Pourhoseini SA; Sahebkar-Khorasani M; Azizi H
Complement Ther Med; 2019 Jun; 44():166-173. PubMed ID: 31126551
[TBL] [Abstract][Full Text] [Related]
47. Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial.
Capriglione S; Plotti F; Montera R; Luvero D; Lopez S; Scaletta G; Aloisi A; Serra GB; Angioli R
Gynecol Oncol; 2016 Dec; 143(3):584-588. PubMed ID: 27751589
[TBL] [Abstract][Full Text] [Related]
48. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
[TBL] [Abstract][Full Text] [Related]
49. Treatment of menopausal hot flashes with 5-hydroxytryptophan.
Freedman RR
Maturitas; 2010 Apr; 65(4):383-5. PubMed ID: 20031347
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of a Homeopathic Medicine of Capsicum frutescens L. (Solanaceae) in the Treatment of Hot Flashes in Menopausal Women: A Phase-2 Randomized Controlled Trial.
Andrade DCDS; Carmona F; Angelucci MA; Martinez EZ; Pereira AMS
Homeopathy; 2019 May; 108(2):102-107. PubMed ID: 30736083
[TBL] [Abstract][Full Text] [Related]
51. Clinical investigation of RAD1901, a novel estrogen receptor ligand, for the treatment of postmenopausal vasomotor symptoms: a phase 2 randomized, placebo-controlled, double-blind, dose-ranging, proof-of-concept trial.
Hattersley G; Harris AG; Simon JA; Constantine GD
Menopause; 2017 Jan; 24(1):92-99. PubMed ID: 27575546
[TBL] [Abstract][Full Text] [Related]
52. A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder.
Mischoulon D; Price LH; Carpenter LL; Tyrka AR; Papakostas GI; Baer L; Dording CM; Clain AJ; Durham K; Walker R; Ludington E; Fava M
J Clin Psychiatry; 2014 Apr; 75(4):370-6. PubMed ID: 24500245
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of citalopram on climacteric symptoms.
Kalay AE; Demir B; Haberal A; Kalay M; Kandemir O
Menopause; 2007; 14(2):223-9. PubMed ID: 17224858
[TBL] [Abstract][Full Text] [Related]
54. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial.
Robinson RG; Jorge RE; Moser DJ; Acion L; Solodkin A; Small SL; Fonzetti P; Hegel M; Arndt S
JAMA; 2008 May; 299(20):2391-400. PubMed ID: 18505948
[TBL] [Abstract][Full Text] [Related]
55. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
Pollack M; Kinrys G; Krystal A; McCall WV; Roth T; Schaefer K; Rubens R; Roach J; Huang H; Krishnan R
Arch Gen Psychiatry; 2008 May; 65(5):551-62. PubMed ID: 18458207
[TBL] [Abstract][Full Text] [Related]
56. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial.
Pandya KJ; Morrow GR; Roscoe JA; Zhao H; Hickok JT; Pajon E; Sweeney TJ; Banerjee TK; Flynn PJ
Lancet; 2005 Sep 3-9; 366(9488):818-24. PubMed ID: 16139656
[TBL] [Abstract][Full Text] [Related]
57. Continuous transdermal nitroglycerin therapy for menopausal hot flashes: a single-arm, dose-escalation trial.
Huang AJ; Cummings SR; Schembri M; Vittinghoff E; Ganz P; Grady D
Menopause; 2016 Mar; 23(3):330-4. PubMed ID: 26263283
[TBL] [Abstract][Full Text] [Related]
58. The effect of oral evening primrose oil on menopausal hot flashes: a randomized clinical trial.
Farzaneh F; Fatehi S; Sohrabi MR; Alizadeh K
Arch Gynecol Obstet; 2013 Nov; 288(5):1075-9. PubMed ID: 23625331
[TBL] [Abstract][Full Text] [Related]
59. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.
Loprinzi CL; Flynn PJ; Carpenter LA; Atherton P; Barton DL; Shanafelt TD; Rummans TA; Sloan JA; Adjei AA; Mincey BA; Fitch TR; Collins M
J Palliat Med; 2005 Oct; 8(5):924-30. PubMed ID: 16238505
[TBL] [Abstract][Full Text] [Related]
60. The effect of vitamin E on hot flashes in menopausal women.
Ziaei S; Kazemnejad A; Zareai M
Gynecol Obstet Invest; 2007; 64(4):204-7. PubMed ID: 17664882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
